Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018

EAST LONDON, U.K. - Oct. 24, 2014 - PRLog -- Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018 is a new market report announced by Reportstack. Preimplantation genetic diagnosis (PGD) testing involves the identification of genetic defects in embryos. It is performed to identify single gene disorders such as Sickle Cell Anemia, Cystic Fibrosis, Huntington’s Disease, Hemophilia, Marfan’s Disease, Thalassemia, Muscular Dystrophy, Tay Sachs, and Spinal Muscular Atrophy. PGD tests are generally carried out in cases of a known genetic defect, or in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and SNP are some of the common technologies used in PGD testing with PCR the most widely used. FISH technology is beneficial in the determination of chromosomal abnormalities, X-linked diseases, and aneuploidy screening. CGH and SNP are advanced technologies, which have high accuracy in screening and diagnosis.

TechNavio's analysts forecast the Global Preimplantation Genetic Diagnosis market to grow at a CAGR of 6.30 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Preimplantation Genetic Diagnosis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of PGD services and products including kits and instruments used for PGD.
TechNavio's report, the Global Preimplantation Genetic Diagnosis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preimplantation Genetic Diagnosis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Genesis Genetics
• Laboratory Corporation of America
• Reproductive Genetics Institute
• Reprogenetics
Other Prominent Vendors

• Abbott Laboratories
• F. Hoffmann-La Roche
• Illumina
• Natera
• PerkinElmer
Market Driver
• Increasing Rate of Infertility
• For a full, detailed list, view our report
Market Challenge
• High Costs of PGD
• For a full, detailed list, view our report
Market Trend
• Growing Opportunity for Direct-to-Consumer Genetic Testing
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Companies Mentioned

Genesis Genetics,Laboratory Corporation of America ,Reproductive Genetics Institute,Reprogenetics ,Abbott Laboratories,F. Hoffmann-La Roche,Illumina ,Natera,PerkinElmer

Complete report available @ http://www.reportstack.com/product/179805/global-preimpla...